SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3x1b'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1J7K_A_ACTA701_0
(HOLLIDAY JUNCTION
DNA HELICASE RUVB)		 3x1b LACCASE
(Lentinus) 		4 / 4 GLY A 196
LEU A 206
GLY A 204
ARG A 197
 None
 0.99A 1j7kA-3x1bA:
undetectable		 1j7kA-3x1bA:
22.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RA8_A_FOLA161_1
(DIHYDROFOLATE
REDUCTASE)		 3x1b LACCASE
(Lentinus) 		3 / 3 ASP A 152
LYS A 156
ARG A 216
 None
 1.17A 1ra8A-3x1bA:
undetectable		 1ra8A-3x1bA:
15.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1WSV_A_THHA3001_0
(AMINOMETHYLTRANSFERA
SE)		 3x1b LACCASE
(Lentinus) 		5 / 12 THR A 165
ILE A 209
VAL A 208
PHE A 267
LEU A 169
 None
 1.27A 1wsvA-3x1bA:
undetectable		 1wsvA-3x1bA:
21.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1WSV_B_THHB4001_0
(AMINOMETHYLTRANSFERA
SE)		 3x1b LACCASE
(Lentinus) 		5 / 12 THR A 165
ILE A 209
VAL A 208
PHE A 267
LEU A 169
 None
 1.29A 1wsvB-3x1bA:
undetectable		 1wsvB-3x1bA:
21.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FQE_A_CUA603_0
(BLUE COPPER OXIDASE
CUEO)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A  85
HIS A  87
HIS A 420
HIS A 422
 CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
 0.27A 2fqeA-3x1bA:
32.5		 2fqeA-3x1bA:
23.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FQE_A_CUA603_0
(BLUE COPPER OXIDASE
CUEO)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 420
HIS A 422
HIS A  85
HIS A  87
 CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
 0.85A 2fqeA-3x1bA:
32.5		 2fqeA-3x1bA:
23.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FQF_A_CUA603_0
(BLUE COPPER OXIDASE
CUEO)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A  85
HIS A  87
HIS A 420
HIS A 422
 CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
 0.23A 2fqfA-3x1bA:
32.3		 2fqfA-3x1bA:
23.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FQF_A_CUA603_0
(BLUE COPPER OXIDASE
CUEO)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 132
HIS A  85
HIS A 422
HIS A 474
 CU  A 616 (-3.2A)
CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 616 (-3.2A)
 1.37A 2fqfA-3x1bA:
32.3		 2fqfA-3x1bA:
23.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FQF_A_CUA603_0
(BLUE COPPER OXIDASE
CUEO)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 420
HIS A 422
HIS A  85
HIS A  87
 CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
 0.82A 2fqfA-3x1bA:
32.3		 2fqfA-3x1bA:
23.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FQG_A_CUA603_0
(BLUE COPPER OXIDASE
CUEO)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A  85
HIS A  87
HIS A 420
HIS A 422
 CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
 0.21A 2fqgA-3x1bA:
32.4		 2fqgA-3x1bA:
23.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FQG_A_CUA603_0
(BLUE COPPER OXIDASE
CUEO)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 420
HIS A 422
HIS A  85
HIS A  87
 CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
 0.81A 2fqgA-3x1bA:
32.4		 2fqgA-3x1bA:
23.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2OQE_E_CUE801_0
(PEROXISOMAL COPPER
AMINE OXIDASE)		 3x1b LACCASE
(Lentinus) 		4 / 4 LEU A 481
HIS A 420
HIS A 474
HIS A 476
 None
CU  A 614 (-3.1A)
CU  A 616 (-3.2A)
CU  A 615 (-3.2A)
 1.23A 2oqeE-3x1bA:
undetectable		 2oqeE-3x1bA:
21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Q6H_A_CXXA802_1
(TRANSPORTER)		 3x1b LACCASE
(Lentinus) 		4 / 7 ILE A 259
ARG A 281
ILE A 234
PHE A 267
 None
 1.02A 2q6hA-3x1bA:
undetectable		 2q6hA-3x1bA:
24.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QWX_B_ML1B233_1
(RIBOSYLDIHYDRONICOTI
NAMIDE DEHYDROGENASE
[QUINONE])		 3x1b LACCASE
(Lentinus) 		4 / 7 GLY A  24
GLY A 125
PHE A  89
PHE A 118
 None
 0.97A 2qwxA-3x1bA:
undetectable
2qwxB-3x1bA:
undetectable		 2qwxA-3x1bA:
19.54
2qwxB-3x1bA:
19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2WKO_A_CUA154_0
(SUPEROXIDE DISMUTASE
[CU-ZN])		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A  85
HIS A 132
HIS A 130
HIS A 422
 CU  A 614 (-3.1A)
CU  A 616 (-3.2A)
CU  A 615 (-3.2A)
CU  A 616 ( 3.2A)
 0.93A 2wkoA-3x1bA:
undetectable		 2wkoA-3x1bA:
15.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2WKO_F_CUF154_0
(SUPEROXIDE DISMUTASE
[CU-ZN])		 3x1b LACCASE
(Lentinus) 		4 / 5 HIS A  85
HIS A 132
HIS A 130
HIS A 422
 CU  A 614 (-3.1A)
CU  A 616 (-3.2A)
CU  A 615 (-3.2A)
CU  A 616 ( 3.2A)
 1.00A 2wkoF-3x1bA:
undetectable		 2wkoF-3x1bA:
15.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y00_B_Y00B601_2
(BETA-1 ADRENERGIC
RECEPTOR)		 3x1b LACCASE
(Lentinus) 		3 / 3 VAL A 488
ASN A 104
TRP A 506
 None
 1.14A 2y00B-3x1bA:
undetectable		 2y00B-3x1bA:
20.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3B0W_A_DGXA1_1
(NUCLEAR RECEPTOR
ROR-GAMMA)		 3x1b LACCASE
(Lentinus) 		5 / 12 LEU A 493
ALA A 490
VAL A 393
LEU A 481
HIS A 132
 None
None
None
None
CU  A 616 (-3.2A)
 1.22A 3b0wA-3x1bA:
undetectable		 3b0wA-3x1bA:
17.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3BWM_A_SAMA301_0
(CATECHOL
O-METHYLTRANSFERASE)		 3x1b LACCASE
(Lentinus) 		5 / 12 VAL A 373
GLY A 100
ILE A  84
SER A 131
GLN A 136
 None
 1.49A 3bwmA-3x1bA:
undetectable		 3bwmA-3x1bA:
21.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3BWY_A_SAMA301_0
(COMT PROTEIN)		 3x1b LACCASE
(Lentinus) 		5 / 12 VAL A 373
GLY A 100
ILE A  84
SER A 131
GLN A 136
 None
 1.45A 3bwyA-3x1bA:
undetectable		 3bwyA-3x1bA:
20.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3CCF_A_BEZA261_0
(CYCLOPROPANE-FATTY-A
CYL-PHOSPHOLIPID
SYNTHASE)		 3x1b LACCASE
(Lentinus) 		4 / 8 HIS A  85
GLY A 100
ASN A 104
TRP A 471
 CU  A 614 (-3.1A)
None
None
None
 1.16A 3ccfA-3x1bA:
undetectable		 3ccfA-3x1bA:
19.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DZG_A_NCAA302_0
(ADP-RIBOSYL CYCLASE
1)		 3x1b LACCASE
(Lentinus) 		4 / 7 LEU A 206
GLU A 309
TRP A 279
SER A 297
 None
 1.31A 3dzgA-3x1bA:
undetectable		 3dzgA-3x1bA:
19.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DZG_B_NCAB302_0
(ADP-RIBOSYL CYCLASE
1)		 3x1b LACCASE
(Lentinus) 		4 / 7 LEU A 206
GLU A 309
TRP A 279
SER A 297
 None
 1.30A 3dzgB-3x1bA:
undetectable		 3dzgB-3x1bA:
19.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HCR_A_CHDA424_0
(FERROCHELATASE,
MITOCHONDRIAL)		 3x1b LACCASE
(Lentinus) 		4 / 8 LEU A 481
ARG A 178
PRO A 389
SER A 392
 None
 1.15A 3hcrA-3x1bA:
undetectable		 3hcrA-3x1bA:
21.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KO0_O_TFPO201_1
(PROTEIN S100-A4)		 3x1b LACCASE
(Lentinus) 		4 / 8 GLY A 262
PHE A  65
GLY A  88
PHE A  89
 None
 0.91A 3ko0O-3x1bA:
undetectable
3ko0Q-3x1bA:
undetectable		 3ko0O-3x1bA:
10.60
3ko0Q-3x1bA:
10.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MBG_A_ACTA206_0
(FAD-LINKED
SULFHYDRYL OXIDASE
ALR)		 3x1b LACCASE
(Lentinus) 		4 / 4 ASP A 139
ARG A 178
THR A 135
ALA A 177
 None
 1.40A 3mbgA-3x1bA:
undetectable		 3mbgA-3x1bA:
11.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MIH_A_CUA357_0
(PEPTIDYL-GLYCINE
ALPHA-AMIDATING
MONOOXYGENASE)		 3x1b LACCASE
(Lentinus) 		3 / 3 HIS A 474
HIS A 420
HIS A 422
 CU  A 616 (-3.2A)
CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
 0.80A 3mihA-3x1bA:
undetectable		 3mihA-3x1bA:
20.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3QPK_A_CUA601_0
(LACCASE-1)		 3x1b LACCASE
(Lentinus) 		4 / 5 HIS A 417
CYH A 475
ILE A 477
HIS A 480
 CU  A 617 (-3.1A)
CU  A 617 (-2.2A)
CU  A 617 ( 3.8A)
CU  A 617 (-3.1A)
 0.29A 3qpkA-3x1bA:
42.8		 3qpkA-3x1bA:
32.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3QPK_A_CUA602_0
(LACCASE-1)		 3x1b LACCASE
(Lentinus) 		3 / 3 HIS A 132
HIS A 422
HIS A 474
 CU  A 616 (-3.2A)
CU  A 616 ( 3.2A)
CU  A 616 (-3.2A)
 0.16A 3qpkA-3x1bA:
42.8		 3qpkA-3x1bA:
32.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3QPK_A_CUA603_0
(LACCASE-1)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A  87
TRP A 128
HIS A 130
HIS A 476
 CU  A 615 ( 3.1A)
CU  A 615 (-4.2A)
CU  A 615 (-3.2A)
CU  A 615 (-3.2A)
 0.23A 3qpkA-3x1bA:
42.8		 3qpkA-3x1bA:
32.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3QPK_A_CUA604_0
(LACCASE-1)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A  85
HIS A  87
HIS A 420
HIS A 422
 CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
 0.26A 3qpkA-3x1bA:
42.8		 3qpkA-3x1bA:
32.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3QPK_A_CUA604_0
(LACCASE-1)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 420
HIS A 422
HIS A  85
HIS A  87
 CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
 0.87A 3qpkA-3x1bA:
42.8		 3qpkA-3x1bA:
32.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3QPK_A_CUA604_0
(LACCASE-1)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 474
HIS A 420
HIS A 422
HIS A 132
 CU  A 616 (-3.2A)
CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 616 (-3.2A)
 1.35A 3qpkA-3x1bA:
42.8		 3qpkA-3x1bA:
32.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3QPK_B_CUB601_0
(LACCASE-1)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 417
CYH A 475
ILE A 477
HIS A 480
 CU  A 617 (-3.1A)
CU  A 617 (-2.2A)
CU  A 617 ( 3.8A)
CU  A 617 (-3.1A)
 0.29A 3qpkB-3x1bA:
42.7		 3qpkB-3x1bA:
32.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3QPK_B_CUB602_0
(LACCASE-1)		 3x1b LACCASE
(Lentinus) 		3 / 3 HIS A 132
HIS A 422
HIS A 474
 CU  A 616 (-3.2A)
CU  A 616 ( 3.2A)
CU  A 616 (-3.2A)
 0.16A 3qpkB-3x1bA:
42.7		 3qpkB-3x1bA:
32.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3QPK_B_CUB603_0
(LACCASE-1)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A  87
TRP A 128
HIS A 130
HIS A 476
 CU  A 615 ( 3.1A)
CU  A 615 (-4.2A)
CU  A 615 (-3.2A)
CU  A 615 (-3.2A)
 0.21A 3qpkB-3x1bA:
42.7		 3qpkB-3x1bA:
32.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3QPK_B_CUB604_0
(LACCASE-1)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A  85
HIS A  87
HIS A 420
HIS A 422
 CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
 0.23A 3qpkB-3x1bA:
42.7		 3qpkB-3x1bA:
32.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3QPK_B_CUB604_0
(LACCASE-1)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 132
HIS A  85
HIS A 422
HIS A 474
 CU  A 616 (-3.2A)
CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 616 (-3.2A)
 1.30A 3qpkB-3x1bA:
42.7		 3qpkB-3x1bA:
32.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3QPK_B_CUB604_0
(LACCASE-1)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 420
HIS A 422
HIS A  85
HIS A  87
 CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
 0.84A 3qpkB-3x1bA:
42.7		 3qpkB-3x1bA:
32.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ROP_A_NCAA302_0
(ADP-RIBOSYL CYCLASE
1)		 3x1b LACCASE
(Lentinus) 		4 / 6 LEU A 206
GLU A 309
TRP A 279
SER A 297
 None
 1.31A 3ropA-3x1bA:
undetectable		 3ropA-3x1bA:
17.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3U9F_E_CLME221_1
(CHLORAMPHENICOL
ACETYLTRANSFERASE)		 3x1b LACCASE
(Lentinus) 		3 / 3 PHE A 359
CYH A 475
HIS A 480
 None
CU  A 617 (-2.2A)
CU  A 617 (-3.1A)
 0.97A 3u9fF-3x1bA:
undetectable		 3u9fF-3x1bA:
18.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3U9F_I_CLMI221_0
(CHLORAMPHENICOL
ACETYLTRANSFERASE)		 3x1b LACCASE
(Lentinus) 		3 / 3 PHE A 359
CYH A 475
HIS A 480
 None
CU  A 617 (-2.2A)
CU  A 617 (-3.1A)
 0.92A 3u9fG-3x1bA:
undetectable		 3u9fG-3x1bA:
18.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3U9F_K_CLMK221_1
(CHLORAMPHENICOL
ACETYLTRANSFERASE)		 3x1b LACCASE
(Lentinus) 		3 / 3 PHE A 485
CYH A 475
HIS A 417
 CU  A 617 ( 4.9A)
CU  A 617 (-2.2A)
CU  A 617 (-3.1A)
 1.29A 3u9fL-3x1bA:
undetectable		 3u9fL-3x1bA:
18.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3U9F_R_CLMR221_1
(CHLORAMPHENICOL
ACETYLTRANSFERASE)		 3x1b LACCASE
(Lentinus) 		3 / 3 PHE A 359
CYH A 475
HIS A 480
 None
CU  A 617 (-2.2A)
CU  A 617 (-3.1A)
 0.85A 3u9fS-3x1bA:
undetectable		 3u9fS-3x1bA:
18.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EF3_A_CUA1002_0
(BLUE COPPER OXIDASE
CUEO)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A  87
HIS A 130
HIS A 420
HIS A 476
 CU  A 615 ( 3.1A)
CU  A 615 (-3.2A)
CU  A 614 (-3.1A)
CU  A 615 (-3.2A)
 0.30A 4ef3A-3x1bA:
32.3		 4ef3A-3x1bA:
22.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EF3_A_CUA1002_0
(BLUE COPPER OXIDASE
CUEO)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 422
HIS A 474
HIS A  85
HIS A 132
 CU  A 616 ( 3.2A)
CU  A 616 (-3.2A)
CU  A 614 (-3.1A)
CU  A 616 (-3.2A)
 0.67A 4ef3A-3x1bA:
32.3		 4ef3A-3x1bA:
22.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EF3_A_CUA1003_0
(BLUE COPPER OXIDASE
CUEO)		 3x1b LACCASE
(Lentinus) 		5 / 5 HIS A  85
HIS A 132
HIS A 420
HIS A 422
HIS A 474
 CU  A 614 (-3.1A)
CU  A 616 (-3.2A)
CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 616 (-3.2A)
 0.25A 4ef3A-3x1bA:
32.3		 4ef3A-3x1bA:
22.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EF3_A_CUA1003_0
(BLUE COPPER OXIDASE
CUEO)		 3x1b LACCASE
(Lentinus) 		5 / 5 HIS A 420
HIS A 476
HIS A  85
HIS A  87
HIS A 130
 CU  A 614 (-3.1A)
CU  A 615 (-3.2A)
CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 615 (-3.2A)
 0.62A 4ef3A-3x1bA:
32.3		 4ef3A-3x1bA:
22.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EF3_A_CUA1004_0
(BLUE COPPER OXIDASE
CUEO)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A  85
HIS A  87
HIS A 420
HIS A 422
 CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
 0.23A 4ef3A-3x1bA:
32.3		 4ef3A-3x1bA:
22.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EF3_A_CUA1004_0
(BLUE COPPER OXIDASE
CUEO)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 420
HIS A 422
HIS A  85
HIS A  87
 CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
 0.84A 4ef3A-3x1bA:
32.3		 4ef3A-3x1bA:
22.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4G2Z_A_ID8A711_1
(LACTOTRANSFERRIN)		 3x1b LACCASE
(Lentinus) 		3 / 3 PRO A 184
TYR A 173
GLY A 180
 None
 0.75A 4g2zA-3x1bA:
undetectable		 4g2zA-3x1bA:
20.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KLR_A_CHDA504_0
(FERROCHELATASE,
MITOCHONDRIAL)		 3x1b LACCASE
(Lentinus) 		4 / 7 LEU A 481
ARG A 178
PRO A 389
SER A 392
 None
 1.04A 4klrA-3x1bA:
undetectable		 4klrA-3x1bA:
20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XUE_B_SAMB303_0
(CATECHOL
O-METHYLTRANSFERASE)		 3x1b LACCASE
(Lentinus) 		5 / 12 VAL A 373
GLY A 100
ILE A  84
SER A 131
GLN A 136
 None
 1.49A 4xueB-3x1bA:
undetectable		 4xueB-3x1bA:
20.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A1R_A_STRA600_1
(CYTOCHROME P450 3A4)		 3x1b LACCASE
(Lentinus) 		4 / 5 PHE A  65
PHE A 127
PHE A  89
VAL A 147
 None
 0.96A 5a1rA-3x1bA:
undetectable		 5a1rA-3x1bA:
21.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BPH_B_ACTB404_0
(D-ALANINE--D-ALANINE
LIGASE)		 3x1b LACCASE
(Lentinus) 		4 / 7 TYR A 230
ARG A 142
SER A 223
LEU A 224
 None
 1.05A 5bphB-3x1bA:
undetectable		 5bphB-3x1bA:
20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5CDN_G_EVPG2101_1
(DNA GYRASE SUBUNIT A
DNA GYRASE SUBUNIT
B,DNA GYRASE SUBUNIT
B)		 3x1b LACCASE
(Lentinus) 		4 / 6 SER A 115
GLY A  59
ASP A  63
GLY A  24
 None
 0.83A 5cdnA-3x1bA:
undetectable
5cdnB-3x1bA:
undetectable		 5cdnA-3x1bA:
23.60
5cdnB-3x1bA:
15.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5CDN_N_EVPN2101_1
(DNA GYRASE SUBUNIT A
DNA GYRASE SUBUNIT
B,DNA GYRASE SUBUNIT
B)		 3x1b LACCASE
(Lentinus) 		4 / 6 SER A 115
GLY A  59
ASP A  63
GLY A  24
 None
 0.82A 5cdnR-3x1bA:
undetectable
5cdnS-3x1bA:
undetectable		 5cdnR-3x1bA:
23.60
5cdnS-3x1bA:
15.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5CU6_A_ACTA403_0
(CASEIN KINASE II
SUBUNIT ALPHA)		 3x1b LACCASE
(Lentinus) 		4 / 6 VAL A 147
ASP A 149
PRO A 150
ALA A 124
 None
 0.80A 5cu6A-3x1bA:
undetectable		 5cu6A-3x1bA:
19.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F8Y_A_X6XA201_1
(GALNAC/GAL-SPECIFIC
LECTIN)		 3x1b LACCASE
(Lentinus) 		5 / 9 HIS A 132
GLY A  99
GLY A 100
HIS A 130
HIS A 422
 CU  A 616 (-3.2A)
None
None
CU  A 615 (-3.2A)
CU  A 616 ( 3.2A)
 1.49A 5f8yA-3x1bA:
undetectable		 5f8yA-3x1bA:
14.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F8Y_B_X6XB203_1
(GALNAC/GAL-SPECIFIC
LECTIN)		 3x1b LACCASE
(Lentinus) 		5 / 9 HIS A 132
GLY A  99
GLY A 100
HIS A 130
HIS A 422
 CU  A 616 (-3.2A)
None
None
CU  A 615 (-3.2A)
CU  A 616 ( 3.2A)
 1.49A 5f8yB-3x1bA:
undetectable		 5f8yB-3x1bA:
14.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JH7_B_6K9B503_0
(TUBULIN BETA-2B
CHAIN)		 3x1b LACCASE
(Lentinus) 		5 / 11 ASN A 296
SER A 187
ASP A 171
THR A 190
PRO A 181
 None
 1.40A 5jh7B-3x1bA:
undetectable		 5jh7B-3x1bA:
23.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5LSA_A_SAMA303_0
(CATECHOL
O-METHYLTRANSFERASE)		 3x1b LACCASE
(Lentinus) 		5 / 12 VAL A 373
GLY A 100
ILE A  84
SER A 131
GLN A 136
 None
 1.46A 5lsaA-3x1bA:
undetectable		 5lsaA-3x1bA:
19.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEJ_A_CUA501_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		5 / 5 HIS A  85
HIS A 132
HIS A 420
HIS A 422
HIS A 474
 CU  A 614 (-3.1A)
CU  A 616 (-3.2A)
CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 616 (-3.2A)
 0.16A 5mejA-3x1bA:
63.2		 5mejA-3x1bA:
63.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEJ_A_CUA501_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		5 / 5 HIS A 420
HIS A 476
HIS A  85
HIS A  87
HIS A 130
 CU  A 614 (-3.1A)
CU  A 615 (-3.2A)
CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 615 (-3.2A)
 0.63A 5mejA-3x1bA:
63.2		 5mejA-3x1bA:
63.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEJ_A_CUA502_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		6 / 6 HIS A  85
HIS A  87
TRP A 128
HIS A 130
HIS A 420
HIS A 476
 CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 615 (-4.2A)
CU  A 615 (-3.2A)
CU  A 614 (-3.1A)
CU  A 615 (-3.2A)
 0.16A 5mejA-3x1bA:
63.2		 5mejA-3x1bA:
63.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEJ_A_CUA502_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 6 HIS A  85
HIS A 132
HIS A 420
HIS A 474
 CU  A 614 (-3.1A)
CU  A 616 (-3.2A)
CU  A 614 (-3.1A)
CU  A 616 (-3.2A)
 0.77A 5mejA-3x1bA:
63.2		 5mejA-3x1bA:
63.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEJ_A_CUA502_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		5 / 6 HIS A 420
HIS A 422
HIS A 474
HIS A  85
HIS A 132
 CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 616 (-3.2A)
CU  A 614 (-3.1A)
CU  A 616 (-3.2A)
 0.65A 5mejA-3x1bA:
63.2		 5mejA-3x1bA:
63.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEJ_A_CUA503_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A  85
HIS A  87
HIS A 420
HIS A 422
 CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
 0.16A 5mejA-3x1bA:
63.2		 5mejA-3x1bA:
63.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEJ_A_CUA503_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 132
HIS A  85
HIS A 422
HIS A 474
 CU  A 616 (-3.2A)
CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 616 (-3.2A)
 1.30A 5mejA-3x1bA:
63.2		 5mejA-3x1bA:
63.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEJ_A_CUA503_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 420
HIS A 422
HIS A  85
HIS A  87
 CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
 0.79A 5mejA-3x1bA:
63.2		 5mejA-3x1bA:
63.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEJ_A_CUA504_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 417
CYH A 475
ILE A 477
HIS A 480
 CU  A 617 (-3.1A)
CU  A 617 (-2.2A)
CU  A 617 ( 3.8A)
CU  A 617 (-3.1A)
 0.10A 5mejA-3x1bA:
63.2		 5mejA-3x1bA:
63.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEW_A_CUA501_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		5 / 5 HIS A  85
HIS A 132
HIS A 420
HIS A 422
HIS A 474
 CU  A 614 (-3.1A)
CU  A 616 (-3.2A)
CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 616 (-3.2A)
 0.15A 5mewA-3x1bA:
63.2		 5mewA-3x1bA:
63.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEW_A_CUA501_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		5 / 5 HIS A 420
HIS A 476
HIS A  85
HIS A  87
HIS A 130
 CU  A 614 (-3.1A)
CU  A 615 (-3.2A)
CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 615 (-3.2A)
 0.61A 5mewA-3x1bA:
63.2		 5mewA-3x1bA:
63.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEW_A_CUA501_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		5 / 5 HIS A 474
HIS A 420
HIS A 132
HIS A 422
HIS A  85
 CU  A 616 (-3.2A)
CU  A 614 (-3.1A)
CU  A 616 (-3.2A)
CU  A 616 ( 3.2A)
CU  A 614 (-3.1A)
 1.47A 5mewA-3x1bA:
63.2		 5mewA-3x1bA:
63.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEW_A_CUA502_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		6 / 6 HIS A  85
HIS A  87
TRP A 128
HIS A 130
HIS A 420
HIS A 476
 CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 615 (-4.2A)
CU  A 615 (-3.2A)
CU  A 614 (-3.1A)
CU  A 615 (-3.2A)
 0.15A 5mewA-3x1bA:
63.2		 5mewA-3x1bA:
63.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEW_A_CUA502_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 6 HIS A  85
HIS A 132
HIS A 420
HIS A 474
 CU  A 614 (-3.1A)
CU  A 616 (-3.2A)
CU  A 614 (-3.1A)
CU  A 616 (-3.2A)
 0.77A 5mewA-3x1bA:
63.2		 5mewA-3x1bA:
63.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEW_A_CUA502_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		5 / 6 HIS A 420
HIS A 422
HIS A 474
HIS A  85
HIS A 132
 CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 616 (-3.2A)
CU  A 614 (-3.1A)
CU  A 616 (-3.2A)
 0.65A 5mewA-3x1bA:
63.2		 5mewA-3x1bA:
63.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEW_A_CUA503_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A  85
HIS A  87
HIS A 420
HIS A 422
 CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
 0.17A 5mewA-3x1bA:
63.2		 5mewA-3x1bA:
63.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEW_A_CUA503_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 132
HIS A  85
HIS A 422
HIS A 474
 CU  A 616 (-3.2A)
CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 616 (-3.2A)
 1.30A 5mewA-3x1bA:
63.2		 5mewA-3x1bA:
63.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEW_A_CUA503_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 420
HIS A 422
HIS A  85
HIS A  87
 CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
 0.79A 5mewA-3x1bA:
63.2		 5mewA-3x1bA:
63.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEW_A_CUA504_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 417
CYH A 475
ILE A 477
HIS A 480
 CU  A 617 (-3.1A)
CU  A 617 (-2.2A)
CU  A 617 ( 3.8A)
CU  A 617 (-3.1A)
 0.07A 5mewA-3x1bA:
63.2		 5mewA-3x1bA:
63.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHU_A_CUA501_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		5 / 5 HIS A  85
HIS A 132
HIS A 420
HIS A 422
HIS A 474
 CU  A 614 (-3.1A)
CU  A 616 (-3.2A)
CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 616 (-3.2A)
 0.14A 5mhuA-3x1bA:
63.1		 5mhuA-3x1bA:
63.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHU_A_CUA501_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		5 / 5 HIS A 420
HIS A 476
HIS A  85
HIS A  87
HIS A 130
 CU  A 614 (-3.1A)
CU  A 615 (-3.2A)
CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 615 (-3.2A)
 0.62A 5mhuA-3x1bA:
63.1		 5mhuA-3x1bA:
63.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHU_A_CUA501_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		5 / 5 HIS A 474
HIS A 420
HIS A 132
HIS A 422
HIS A  85
 CU  A 616 (-3.2A)
CU  A 614 (-3.1A)
CU  A 616 (-3.2A)
CU  A 616 ( 3.2A)
CU  A 614 (-3.1A)
 1.47A 5mhuA-3x1bA:
63.1		 5mhuA-3x1bA:
63.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHU_A_CUA502_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		6 / 6 HIS A  85
HIS A  87
TRP A 128
HIS A 130
HIS A 420
HIS A 476
 CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 615 (-4.2A)
CU  A 615 (-3.2A)
CU  A 614 (-3.1A)
CU  A 615 (-3.2A)
 0.14A 5mhuA-3x1bA:
63.1		 5mhuA-3x1bA:
63.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHU_A_CUA502_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 6 HIS A  85
HIS A 132
HIS A 420
HIS A 474
 CU  A 614 (-3.1A)
CU  A 616 (-3.2A)
CU  A 614 (-3.1A)
CU  A 616 (-3.2A)
 0.78A 5mhuA-3x1bA:
63.1		 5mhuA-3x1bA:
63.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHU_A_CUA502_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		5 / 6 HIS A 420
HIS A 422
HIS A 474
HIS A  85
HIS A 132
 CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 616 (-3.2A)
CU  A 614 (-3.1A)
CU  A 616 (-3.2A)
 0.65A 5mhuA-3x1bA:
63.1		 5mhuA-3x1bA:
63.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHU_A_CUA503_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A  85
HIS A  87
HIS A 420
HIS A 422
 CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
 0.14A 5mhuA-3x1bA:
63.1		 5mhuA-3x1bA:
63.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHU_A_CUA503_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 132
HIS A  85
HIS A 422
HIS A 474
 CU  A 616 (-3.2A)
CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 616 (-3.2A)
 1.32A 5mhuA-3x1bA:
63.1		 5mhuA-3x1bA:
63.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHU_A_CUA503_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 420
HIS A 422
HIS A  85
HIS A  87
 CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
 0.79A 5mhuA-3x1bA:
63.1		 5mhuA-3x1bA:
63.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHU_A_CUA504_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 417
CYH A 475
ILE A 477
HIS A 480
 CU  A 617 (-3.1A)
CU  A 617 (-2.2A)
CU  A 617 ( 3.8A)
CU  A 617 (-3.1A)
 0.06A 5mhuA-3x1bA:
63.1		 5mhuA-3x1bA:
63.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHV_A_CUA501_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		5 / 5 HIS A  85
HIS A 132
HIS A 420
HIS A 422
HIS A 474
 CU  A 614 (-3.1A)
CU  A 616 (-3.2A)
CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 616 (-3.2A)
 0.13A 5mhvA-3x1bA:
63.1		 5mhvA-3x1bA:
63.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHV_A_CUA501_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		5 / 5 HIS A 132
HIS A  85
HIS A 476
HIS A 130
HIS A  87
 CU  A 616 (-3.2A)
CU  A 614 (-3.1A)
CU  A 615 (-3.2A)
CU  A 615 (-3.2A)
CU  A 615 ( 3.1A)
 1.42A 5mhvA-3x1bA:
63.1		 5mhvA-3x1bA:
63.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHV_A_CUA501_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		5 / 5 HIS A 420
HIS A 476
HIS A  85
HIS A  87
HIS A 130
 CU  A 614 (-3.1A)
CU  A 615 (-3.2A)
CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 615 (-3.2A)
 0.62A 5mhvA-3x1bA:
63.1		 5mhvA-3x1bA:
63.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHV_A_CUA501_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		5 / 5 HIS A 474
HIS A 420
HIS A 132
HIS A 422
HIS A  85
 CU  A 616 (-3.2A)
CU  A 614 (-3.1A)
CU  A 616 (-3.2A)
CU  A 616 ( 3.2A)
CU  A 614 (-3.1A)
 1.47A 5mhvA-3x1bA:
63.1		 5mhvA-3x1bA:
63.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHV_A_CUA502_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		6 / 6 HIS A  85
HIS A  87
TRP A 128
HIS A 130
HIS A 420
HIS A 476
 CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 615 (-4.2A)
CU  A 615 (-3.2A)
CU  A 614 (-3.1A)
CU  A 615 (-3.2A)
 0.14A 5mhvA-3x1bA:
63.1		 5mhvA-3x1bA:
63.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHV_A_CUA502_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 6 HIS A  85
HIS A 132
HIS A 420
HIS A 474
 CU  A 614 (-3.1A)
CU  A 616 (-3.2A)
CU  A 614 (-3.1A)
CU  A 616 (-3.2A)
 0.77A 5mhvA-3x1bA:
63.1		 5mhvA-3x1bA:
63.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHV_A_CUA502_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		5 / 6 HIS A 420
HIS A 422
HIS A 474
HIS A  85
HIS A 132
 CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 616 (-3.2A)
CU  A 614 (-3.1A)
CU  A 616 (-3.2A)
 0.66A 5mhvA-3x1bA:
63.1		 5mhvA-3x1bA:
63.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHV_A_CUA503_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A  85
HIS A  87
HIS A 420
HIS A 422
 CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
 0.14A 5mhvA-3x1bA:
63.1		 5mhvA-3x1bA:
63.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHV_A_CUA503_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 420
HIS A 422
HIS A  85
HIS A  87
 CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
 0.79A 5mhvA-3x1bA:
63.1		 5mhvA-3x1bA:
63.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHV_A_CUA504_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 417
CYH A 475
ILE A 477
HIS A 480
 CU  A 617 (-3.1A)
CU  A 617 (-2.2A)
CU  A 617 ( 3.8A)
CU  A 617 (-3.1A)
 0.06A 5mhvA-3x1bA:
63.1		 5mhvA-3x1bA:
63.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHW_A_CUA601_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 132
HIS A 420
HIS A 422
HIS A 474
 CU  A 616 (-3.2A)
CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 616 (-3.2A)
 0.11A 5mhwA-3x1bA:
63.1		 5mhwA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHW_A_CUA601_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 476
HIS A  85
HIS A  87
HIS A 130
 CU  A 615 (-3.2A)
CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 615 (-3.2A)
 0.68A 5mhwA-3x1bA:
63.1		 5mhwA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHW_A_CUA602_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		5 / 5 HIS A  85
HIS A  87
TRP A 128
HIS A 130
HIS A 476
 CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 615 (-4.2A)
CU  A 615 (-3.2A)
CU  A 615 (-3.2A)
 0.13A 5mhwA-3x1bA:
63.1		 5mhwA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHW_A_CUA602_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 5 HIS A 420
HIS A 422
HIS A 474
HIS A 132
 CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 616 (-3.2A)
CU  A 616 (-3.2A)
 0.72A 5mhwA-3x1bA:
63.1		 5mhwA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHW_A_CUA602_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 5 HIS A 476
HIS A 420
HIS A 474
HIS A 422
 CU  A 615 (-3.2A)
CU  A 614 (-3.1A)
CU  A 616 (-3.2A)
CU  A 616 ( 3.2A)
 0.84A 5mhwA-3x1bA:
63.1		 5mhwA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHW_A_CUA603_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A  85
HIS A  87
HIS A 420
HIS A 422
 CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
 0.14A 5mhwA-3x1bA:
63.1		 5mhwA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHW_A_CUA603_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 420
HIS A 422
HIS A  85
HIS A  87
 CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
 0.79A 5mhwA-3x1bA:
63.1		 5mhwA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHW_A_CUA604_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 417
CYH A 475
ILE A 477
HIS A 480
 CU  A 617 (-3.1A)
CU  A 617 (-2.2A)
CU  A 617 ( 3.8A)
CU  A 617 (-3.1A)
 0.06A 5mhwA-3x1bA:
63.1		 5mhwA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHX_A_CUA601_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 132
HIS A 420
HIS A 422
HIS A 474
 CU  A 616 (-3.2A)
CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 616 (-3.2A)
 0.10A 5mhxA-3x1bA:
63.1		 5mhxA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHX_A_CUA601_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 476
HIS A  85
HIS A  87
HIS A 130
 CU  A 615 (-3.2A)
CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 615 (-3.2A)
 0.69A 5mhxA-3x1bA:
63.1		 5mhxA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHX_A_CUA602_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		5 / 5 HIS A  85
HIS A  87
TRP A 128
HIS A 130
HIS A 476
 CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 615 (-4.2A)
CU  A 615 (-3.2A)
CU  A 615 (-3.2A)
 0.13A 5mhxA-3x1bA:
63.1		 5mhxA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHX_A_CUA602_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 5 HIS A 420
HIS A 422
HIS A 474
HIS A 132
 CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 616 (-3.2A)
CU  A 616 (-3.2A)
 0.72A 5mhxA-3x1bA:
63.1		 5mhxA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHX_A_CUA602_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 5 HIS A 476
HIS A 420
HIS A 474
HIS A 422
 CU  A 615 (-3.2A)
CU  A 614 (-3.1A)
CU  A 616 (-3.2A)
CU  A 616 ( 3.2A)
 0.84A 5mhxA-3x1bA:
63.1		 5mhxA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHX_A_CUA603_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A  85
HIS A  87
HIS A 420
HIS A 422
 CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
 0.13A 5mhxA-3x1bA:
63.1		 5mhxA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHX_A_CUA603_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 420
HIS A 422
HIS A  85
HIS A  87
 CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
 0.80A 5mhxA-3x1bA:
63.1		 5mhxA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHX_A_CUA604_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 417
CYH A 475
ILE A 477
HIS A 480
 CU  A 617 (-3.1A)
CU  A 617 (-2.2A)
CU  A 617 ( 3.8A)
CU  A 617 (-3.1A)
 0.06A 5mhxA-3x1bA:
63.1		 5mhxA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHY_A_CUA601_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 132
HIS A 420
HIS A 422
HIS A 474
 CU  A 616 (-3.2A)
CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 616 (-3.2A)
 0.10A 5mhyA-3x1bA:
63.1		 5mhyA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHY_A_CUA601_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 476
HIS A  85
HIS A  87
HIS A 130
 CU  A 615 (-3.2A)
CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 615 (-3.2A)
 0.69A 5mhyA-3x1bA:
63.1		 5mhyA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHY_A_CUA602_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		5 / 5 HIS A  85
HIS A  87
TRP A 128
HIS A 130
HIS A 476
 CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 615 (-4.2A)
CU  A 615 (-3.2A)
CU  A 615 (-3.2A)
 0.13A 5mhyA-3x1bA:
63.1		 5mhyA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHY_A_CUA602_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 5 HIS A 420
HIS A 422
HIS A 474
HIS A 132
 CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 616 (-3.2A)
CU  A 616 (-3.2A)
 0.72A 5mhyA-3x1bA:
63.1		 5mhyA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHY_A_CUA602_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 5 HIS A 476
HIS A 420
HIS A 474
HIS A 422
 CU  A 615 (-3.2A)
CU  A 614 (-3.1A)
CU  A 616 (-3.2A)
CU  A 616 ( 3.2A)
 0.84A 5mhyA-3x1bA:
63.1		 5mhyA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHY_A_CUA603_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A  85
HIS A  87
HIS A 420
HIS A 422
 CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
 0.13A 5mhyA-3x1bA:
63.1		 5mhyA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHY_A_CUA603_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 420
HIS A 422
HIS A  85
HIS A  87
 CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
 0.79A 5mhyA-3x1bA:
63.1		 5mhyA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHY_A_CUA604_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 417
CYH A 475
ILE A 477
HIS A 480
 CU  A 617 (-3.1A)
CU  A 617 (-2.2A)
CU  A 617 ( 3.8A)
CU  A 617 (-3.1A)
 0.06A 5mhyA-3x1bA:
63.1		 5mhyA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHZ_A_CUA601_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 132
HIS A 420
HIS A 422
HIS A 474
 CU  A 616 (-3.2A)
CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 616 (-3.2A)
 0.10A 5mhzA-3x1bA:
63.1		 5mhzA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHZ_A_CUA601_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 476
HIS A  85
HIS A  87
HIS A 130
 CU  A 615 (-3.2A)
CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 615 (-3.2A)
 0.69A 5mhzA-3x1bA:
63.1		 5mhzA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHZ_A_CUA602_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		5 / 5 HIS A  85
HIS A  87
TRP A 128
HIS A 130
HIS A 476
 CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 615 (-4.2A)
CU  A 615 (-3.2A)
CU  A 615 (-3.2A)
 0.13A 5mhzA-3x1bA:
63.1		 5mhzA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHZ_A_CUA602_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 5 HIS A 420
HIS A 422
HIS A 474
HIS A 132
 CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 616 (-3.2A)
CU  A 616 (-3.2A)
 0.72A 5mhzA-3x1bA:
63.1		 5mhzA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHZ_A_CUA602_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 5 HIS A 476
HIS A 420
HIS A 474
HIS A 422
 CU  A 615 (-3.2A)
CU  A 614 (-3.1A)
CU  A 616 (-3.2A)
CU  A 616 ( 3.2A)
 0.84A 5mhzA-3x1bA:
63.1		 5mhzA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHZ_A_CUA603_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A  85
HIS A  87
HIS A 420
HIS A 422
 CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
 0.14A 5mhzA-3x1bA:
63.1		 5mhzA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHZ_A_CUA603_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 420
HIS A 422
HIS A  85
HIS A  87
 CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
 0.80A 5mhzA-3x1bA:
63.1		 5mhzA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHZ_A_CUA604_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 417
CYH A 475
ILE A 477
HIS A 480
 CU  A 617 (-3.1A)
CU  A 617 (-2.2A)
CU  A 617 ( 3.8A)
CU  A 617 (-3.1A)
 0.06A 5mhzA-3x1bA:
63.1		 5mhzA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI1_A_CUA601_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 132
HIS A 420
HIS A 422
HIS A 474
 CU  A 616 (-3.2A)
CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 616 (-3.2A)
 0.10A 5mi1A-3x1bA:
63.1		 5mi1A-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI1_A_CUA601_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 476
HIS A  85
HIS A  87
HIS A 130
 CU  A 615 (-3.2A)
CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 615 (-3.2A)
 0.69A 5mi1A-3x1bA:
63.1		 5mi1A-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI1_A_CUA602_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		5 / 5 HIS A  85
HIS A  87
TRP A 128
HIS A 130
HIS A 476
 CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 615 (-4.2A)
CU  A 615 (-3.2A)
CU  A 615 (-3.2A)
 0.13A 5mi1A-3x1bA:
63.1		 5mi1A-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI1_A_CUA602_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 5 HIS A 420
HIS A 422
HIS A 474
HIS A 132
 CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 616 (-3.2A)
CU  A 616 (-3.2A)
 0.72A 5mi1A-3x1bA:
63.1		 5mi1A-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI1_A_CUA602_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 5 HIS A 476
HIS A 420
HIS A 474
HIS A 422
 CU  A 615 (-3.2A)
CU  A 614 (-3.1A)
CU  A 616 (-3.2A)
CU  A 616 ( 3.2A)
 0.84A 5mi1A-3x1bA:
63.1		 5mi1A-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI1_A_CUA603_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A  85
HIS A  87
HIS A 420
HIS A 422
 CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
 0.13A 5mi1A-3x1bA:
63.1		 5mi1A-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI1_A_CUA603_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 420
HIS A 422
HIS A  85
HIS A  87
 CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
 0.79A 5mi1A-3x1bA:
63.1		 5mi1A-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI1_A_CUA604_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 417
CYH A 475
ILE A 477
HIS A 480
 CU  A 617 (-3.1A)
CU  A 617 (-2.2A)
CU  A 617 ( 3.8A)
CU  A 617 (-3.1A)
 0.05A 5mi1A-3x1bA:
63.1		 5mi1A-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI2_A_CUA601_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 132
HIS A 420
HIS A 422
HIS A 474
 CU  A 616 (-3.2A)
CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 616 (-3.2A)
 0.10A 5mi2A-3x1bA:
63.1		 5mi2A-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI2_A_CUA601_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 476
HIS A  85
HIS A  87
HIS A 130
 CU  A 615 (-3.2A)
CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 615 (-3.2A)
 0.69A 5mi2A-3x1bA:
63.1		 5mi2A-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI2_A_CUA602_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		5 / 5 HIS A  85
HIS A  87
TRP A 128
HIS A 130
HIS A 476
 CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 615 (-4.2A)
CU  A 615 (-3.2A)
CU  A 615 (-3.2A)
 0.13A 5mi2A-3x1bA:
63.1		 5mi2A-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI2_A_CUA602_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 5 HIS A 420
HIS A 422
HIS A 474
HIS A 132
 CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 616 (-3.2A)
CU  A 616 (-3.2A)
 0.72A 5mi2A-3x1bA:
63.1		 5mi2A-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI2_A_CUA602_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 5 HIS A 476
HIS A 420
HIS A 474
HIS A 422
 CU  A 615 (-3.2A)
CU  A 614 (-3.1A)
CU  A 616 (-3.2A)
CU  A 616 ( 3.2A)
 0.84A 5mi2A-3x1bA:
63.1		 5mi2A-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI2_A_CUA603_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A  85
HIS A  87
HIS A 420
HIS A 422
 CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
 0.13A 5mi2A-3x1bA:
63.1		 5mi2A-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI2_A_CUA603_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 420
HIS A 422
HIS A  85
HIS A  87
 CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
 0.79A 5mi2A-3x1bA:
63.1		 5mi2A-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI2_A_CUA604_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 417
CYH A 475
ILE A 477
HIS A 480
 CU  A 617 (-3.1A)
CU  A 617 (-2.2A)
CU  A 617 ( 3.8A)
CU  A 617 (-3.1A)
 0.05A 5mi2A-3x1bA:
63.1		 5mi2A-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIA_A_CUA601_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 132
HIS A 420
HIS A 422
HIS A 474
 CU  A 616 (-3.2A)
CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 616 (-3.2A)
 0.10A 5miaA-3x1bA:
63.2		 5miaA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIA_A_CUA601_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 476
HIS A  85
HIS A  87
HIS A 130
 CU  A 615 (-3.2A)
CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 615 (-3.2A)
 0.69A 5miaA-3x1bA:
63.2		 5miaA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIA_A_CUA602_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		5 / 5 HIS A  85
HIS A  87
TRP A 128
HIS A 130
HIS A 476
 CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 615 (-4.2A)
CU  A 615 (-3.2A)
CU  A 615 (-3.2A)
 0.13A 5miaA-3x1bA:
63.2		 5miaA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIA_A_CUA602_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 5 HIS A 420
HIS A 422
HIS A 474
HIS A 132
 CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 616 (-3.2A)
CU  A 616 (-3.2A)
 0.72A 5miaA-3x1bA:
63.2		 5miaA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIA_A_CUA602_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 5 HIS A 476
HIS A 420
HIS A 474
HIS A 422
 CU  A 615 (-3.2A)
CU  A 614 (-3.1A)
CU  A 616 (-3.2A)
CU  A 616 ( 3.2A)
 0.84A 5miaA-3x1bA:
63.2		 5miaA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIA_A_CUA603_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A  85
HIS A  87
HIS A 420
HIS A 422
 CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
 0.13A 5miaA-3x1bA:
63.2		 5miaA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIA_A_CUA603_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 420
HIS A 422
HIS A  85
HIS A  87
 CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
 0.79A 5miaA-3x1bA:
63.2		 5miaA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIA_A_CUA604_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 417
CYH A 475
ILE A 477
HIS A 480
 CU  A 617 (-3.1A)
CU  A 617 (-2.2A)
CU  A 617 ( 3.8A)
CU  A 617 (-3.1A)
 0.06A 5miaA-3x1bA:
63.2		 5miaA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIB_A_CUA601_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 132
HIS A 420
HIS A 422
HIS A 474
 CU  A 616 (-3.2A)
CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 616 (-3.2A)
 0.10A 5mibA-3x1bA:
63.0		 5mibA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIB_A_CUA601_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 476
HIS A  85
HIS A  87
HIS A 130
 CU  A 615 (-3.2A)
CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 615 (-3.2A)
 0.69A 5mibA-3x1bA:
63.0		 5mibA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIB_A_CUA602_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		5 / 5 HIS A  85
HIS A  87
TRP A 128
HIS A 130
HIS A 476
 CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 615 (-4.2A)
CU  A 615 (-3.2A)
CU  A 615 (-3.2A)
 0.13A 5mibA-3x1bA:
63.0		 5mibA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIB_A_CUA602_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 5 HIS A 420
HIS A 422
HIS A 474
HIS A 132
 CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 616 (-3.2A)
CU  A 616 (-3.2A)
 0.72A 5mibA-3x1bA:
63.0		 5mibA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIB_A_CUA602_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 5 HIS A 476
HIS A 420
HIS A 474
HIS A 422
 CU  A 615 (-3.2A)
CU  A 614 (-3.1A)
CU  A 616 (-3.2A)
CU  A 616 ( 3.2A)
 0.84A 5mibA-3x1bA:
63.0		 5mibA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIB_A_CUA603_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A  85
HIS A  87
HIS A 420
HIS A 422
 CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
 0.13A 5mibA-3x1bA:
63.0		 5mibA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIB_A_CUA603_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 420
HIS A 422
HIS A  85
HIS A  87
 CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
 0.79A 5mibA-3x1bA:
63.0		 5mibA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIB_A_CUA604_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 417
CYH A 475
ILE A 477
HIS A 480
 CU  A 617 (-3.1A)
CU  A 617 (-2.2A)
CU  A 617 ( 3.8A)
CU  A 617 (-3.1A)
 0.05A 5mibA-3x1bA:
63.0		 5mibA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIC_A_CUA601_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 132
HIS A 420
HIS A 422
HIS A 474
 CU  A 616 (-3.2A)
CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 616 (-3.2A)
 0.09A 5micA-3x1bA:
63.1		 5micA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIC_A_CUA601_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 476
HIS A  85
HIS A  87
HIS A 130
 CU  A 615 (-3.2A)
CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 615 (-3.2A)
 0.69A 5micA-3x1bA:
63.1		 5micA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIC_A_CUA602_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		5 / 5 HIS A  85
HIS A  87
TRP A 128
HIS A 130
HIS A 476
 CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 615 (-4.2A)
CU  A 615 (-3.2A)
CU  A 615 (-3.2A)
 0.13A 5micA-3x1bA:
63.1		 5micA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIC_A_CUA602_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 5 HIS A 420
HIS A 422
HIS A 474
HIS A 132
 CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 616 (-3.2A)
CU  A 616 (-3.2A)
 0.72A 5micA-3x1bA:
63.1		 5micA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIC_A_CUA602_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 5 HIS A 476
HIS A 420
HIS A 474
HIS A 422
 CU  A 615 (-3.2A)
CU  A 614 (-3.1A)
CU  A 616 (-3.2A)
CU  A 616 ( 3.2A)
 0.84A 5micA-3x1bA:
63.1		 5micA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIC_A_CUA603_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A  85
HIS A  87
HIS A 420
HIS A 422
 CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
 0.13A 5micA-3x1bA:
63.1		 5micA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIC_A_CUA603_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 420
HIS A 422
HIS A  85
HIS A  87
 CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
 0.79A 5micA-3x1bA:
63.1		 5micA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIC_A_CUA604_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 417
CYH A 475
ILE A 477
HIS A 480
 CU  A 617 (-3.1A)
CU  A 617 (-2.2A)
CU  A 617 ( 3.8A)
CU  A 617 (-3.1A)
 0.06A 5micA-3x1bA:
63.1		 5micA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MID_A_CUA601_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 132
HIS A 420
HIS A 422
HIS A 474
 CU  A 616 (-3.2A)
CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 616 (-3.2A)
 0.09A 5midA-3x1bA:
63.1		 5midA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MID_A_CUA601_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 476
HIS A  85
HIS A  87
HIS A 130
 CU  A 615 (-3.2A)
CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 615 (-3.2A)
 0.69A 5midA-3x1bA:
63.1		 5midA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MID_A_CUA602_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		5 / 5 HIS A  85
HIS A  87
TRP A 128
HIS A 130
HIS A 476
 CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 615 (-4.2A)
CU  A 615 (-3.2A)
CU  A 615 (-3.2A)
 0.13A 5midA-3x1bA:
63.1		 5midA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MID_A_CUA602_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 5 HIS A 420
HIS A 422
HIS A 474
HIS A 132
 CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 616 (-3.2A)
CU  A 616 (-3.2A)
 0.72A 5midA-3x1bA:
63.1		 5midA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MID_A_CUA602_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 5 HIS A 476
HIS A 420
HIS A 474
HIS A 422
 CU  A 615 (-3.2A)
CU  A 614 (-3.1A)
CU  A 616 (-3.2A)
CU  A 616 ( 3.2A)
 0.84A 5midA-3x1bA:
63.1		 5midA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MID_A_CUA603_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A  85
HIS A  87
HIS A 420
HIS A 422
 CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
 0.13A 5midA-3x1bA:
63.1		 5midA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MID_A_CUA603_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 420
HIS A 422
HIS A  85
HIS A  87
 CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
 0.79A 5midA-3x1bA:
63.1		 5midA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MID_A_CUA604_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 417
CYH A 475
ILE A 477
HIS A 480
 CU  A 617 (-3.1A)
CU  A 617 (-2.2A)
CU  A 617 ( 3.8A)
CU  A 617 (-3.1A)
 0.05A 5midA-3x1bA:
63.1		 5midA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIE_A_CUA601_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 132
HIS A 420
HIS A 422
HIS A 474
 CU  A 616 (-3.2A)
CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 616 (-3.2A)
 0.10A 5mieA-3x1bA:
63.1		 5mieA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIE_A_CUA601_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 476
HIS A  85
HIS A  87
HIS A 130
 CU  A 615 (-3.2A)
CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 615 (-3.2A)
 0.69A 5mieA-3x1bA:
63.1		 5mieA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIE_A_CUA602_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		5 / 5 HIS A  85
HIS A  87
TRP A 128
HIS A 130
HIS A 476
 CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 615 (-4.2A)
CU  A 615 (-3.2A)
CU  A 615 (-3.2A)
 0.13A 5mieA-3x1bA:
63.1		 5mieA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIE_A_CUA602_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 5 HIS A 420
HIS A 422
HIS A 474
HIS A 132
 CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 616 (-3.2A)
CU  A 616 (-3.2A)
 0.72A 5mieA-3x1bA:
63.1		 5mieA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIE_A_CUA602_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 5 HIS A 476
HIS A 420
HIS A 474
HIS A 422
 CU  A 615 (-3.2A)
CU  A 614 (-3.1A)
CU  A 616 (-3.2A)
CU  A 616 ( 3.2A)
 0.84A 5mieA-3x1bA:
63.1		 5mieA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIE_A_CUA603_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A  85
HIS A  87
HIS A 420
HIS A 422
 CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
 0.13A 5mieA-3x1bA:
63.1		 5mieA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIE_A_CUA603_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 420
HIS A 422
HIS A  85
HIS A  87
 CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
 0.79A 5mieA-3x1bA:
63.1		 5mieA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIE_A_CUA604_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 417
CYH A 475
ILE A 477
HIS A 480
 CU  A 617 (-3.1A)
CU  A 617 (-2.2A)
CU  A 617 ( 3.8A)
CU  A 617 (-3.1A)
 0.06A 5mieA-3x1bA:
63.1		 5mieA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIG_A_CUA601_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		3 / 3 HIS A 132
HIS A 422
HIS A 474
 CU  A 616 (-3.2A)
CU  A 616 ( 3.2A)
CU  A 616 (-3.2A)
 0.06A 5migA-3x1bA:
63.2		 5migA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIG_A_CUA602_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		5 / 5 HIS A  85
HIS A  87
TRP A 128
HIS A 130
HIS A 476
 CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 615 (-4.2A)
CU  A 615 (-3.2A)
CU  A 615 (-3.2A)
 0.13A 5migA-3x1bA:
63.2		 5migA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIG_A_CUA602_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 5 HIS A 420
HIS A 422
HIS A 474
HIS A 132
 CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 616 (-3.2A)
CU  A 616 (-3.2A)
 0.72A 5migA-3x1bA:
63.2		 5migA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIG_A_CUA602_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 5 HIS A 476
HIS A 420
HIS A 474
HIS A 422
 CU  A 615 (-3.2A)
CU  A 614 (-3.1A)
CU  A 616 (-3.2A)
CU  A 616 ( 3.2A)
 0.84A 5migA-3x1bA:
63.2		 5migA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIG_A_CUA603_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A  85
HIS A  87
HIS A 420
HIS A 422
 CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
 0.12A 5migA-3x1bA:
63.2		 5migA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIG_A_CUA603_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 420
HIS A 422
HIS A  85
HIS A  87
 CU  A 614 (-3.1A)
CU  A 616 ( 3.2A)
CU  A 614 (-3.1A)
CU  A 615 ( 3.1A)
 0.79A 5migA-3x1bA:
63.2		 5migA-3x1bA:
62.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIG_A_CUA604_0
(LACCASE 2)		 3x1b LACCASE
(Lentinus) 		4 / 4 HIS A 417
CYH A 475
ILE A 477
HIS A 480
 CU  A 617 (-3.1A)
CU  A 617 (-2.2A)
CU  A 617 ( 3.8A)
CU  A 617 (-3.1A)
 0.06A 5migA-3x1bA:
63.2		 5migA-3x1bA:
62.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5NNW_D_GCSD302_1
(25 KDA PROTEIN
ELICITOR)		 3x1b LACCASE
(Lentinus) 		4 / 7 GLY A 262
HIS A 476
ASP A 478
HIS A  85
 None
CU  A 615 (-3.2A)
None
CU  A 614 (-3.1A)
 1.05A 5nnwD-3x1bA:
undetectable		 5nnwD-3x1bA:
11.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5OTR_A_ACTA402_0
(CASEIN KINASE II
SUBUNIT ALPHA)		 3x1b LACCASE
(Lentinus) 		4 / 5 VAL A 147
ASP A 149
PRO A 150
ALA A 124
 None
 0.82A 5otrA-3x1bA:
undetectable		 5otrA-3x1bA:
19.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TUD_D_ERMD1201_1
(5-HYDROXYTRYPTAMINE
RECEPTOR 2B,SOLUBLE
CYTOCHROME B562
CHIMERA)		 3x1b LACCASE
(Lentinus) 		5 / 12 ALA A 412
PHE A 485
VAL A 448
LEU A 473
VAL A 487
 None
CU  A 617 ( 4.9A)
None
None
None
 1.15A 5tudD-3x1bA:
undetectable		 5tudD-3x1bA:
22.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5WWS_B_SAMB501_0
(PUTATIVE
METHYLTRANSFERASE
NSUN6)		 3x1b LACCASE
(Lentinus) 		5 / 12 GLY A 287
ILE A 192
ASP A 205
GLY A 204
ASP A 188
 None
 1.24A 5wwsB-3x1bA:
undetectable		 5wwsB-3x1bA:
21.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6JNH_A_ASCA201_0
(PHOSPHOPANTETHEINE
ADENYLYLTRANSFERASE)		 3x1b LACCASE
(Lentinus) 		4 / 7 GLY A 125
THR A 126
PHE A 127
ARG A 445
 None
 0.87A 6jnhA-3x1bA:
undetectable		 6jnhA-3x1bA:
15.78